Auxly Cannabis Group Inc. Q4 FY2025 Update – (XLY)

Key Takeaways

• Revenue up 16% YoY, EBITDA margin 31% quarter
• EBITDA beat expectations by ~20%, driving cash flow
• Capital plan expands capex to $12M for Leamington upgrades
• Mix shift to flower and pre‑rolls lifts margins
• International expansion remains early, low‑risk focus

Pulse Analysis

Auxly Cannabis Group’s latest quarter demonstrates how Canadian producers can pivot from pure volume growth to profitability. Revenue rose modestly, but the company’s strategic emphasis on higher‑margin dried flower and pre‑rolls pushed gross margins to 43% under IFRS and delivered an adjusted EBITDA margin of 31%. This mix shift, combined with procurement automation and tighter cost controls, turned incremental sales into near‑linear EBITDA gains, a rare feat in a sector still grappling with price volatility.

Looking ahead, Auxly’s 2026 capital allocation signals a disciplined expansion mindset. The firm plans to invest up to C$12 million—roughly five times its 2025 spend—primarily in Leamington’s post‑harvest infrastructure, including drying, curing, and packaging lines. By enhancing throughput and yield within its existing footprint, Auxly aims to boost per‑plant productivity without the risk of new greenfield builds. This capital‑intensive yet focused approach should improve cash conversion and support the projected free‑cash‑flow generation of C$30‑35 million in 2026.

From a market perspective, Auxly is positioned to outpace the modest 5% Canadian cannabis market growth. Stable pricing, a value‑oriented brand portfolio, and incremental distribution gains underpin its outlook. While international ambitions remain in the early‑stage, the company’s low‑risk M&A filter—exemplified by the Ayurcann opportunity—offers a pathway to diversify product lines without jeopardizing balance‑sheet health. Together, these factors reinforce Auxly’s narrative as a cash‑generating, margin‑rich player in a consolidating industry.